January 12, 2018
Rose
Correction: A previous version of this story mistated the projected timeline for the combined product. It is Q1 this year, not Q1 next year. WellDoc and Voluntis, two companies with FDA-cleared, clinically validated platforms aimed at the management of Type 2 diabetes, have signed a commercial agreement to combine their technologies and offer joint products in the future.
from MobiHealthNews http://ift.tt/2AV4KNT
January 12, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Israeli imaging AI startup Zebra Medical Vision secures $30M backing- Pharma enthusiastic for digital medicine, but some roadblocks remain
- iBeat announces funding, partnership deals with insurers
- Apple adds movement disorder API, plus speech, hearing, and vision tests, to ResearchKit framework
- Inside Apple's integration with Medisafe, the first test of the Apple Health Records API
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment